{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:45:55Z","timestamp":1789501555350,"version":"build-2803163510"},"reference-count":71,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","oooojournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.oooo.2015.01.022","type":"journal-article","created":{"date-parts":[[2015,3,9]],"date-time":"2015-03-09T17:22:50Z","timestamp":1425921770000},"page":"132-142.e61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["World Workshop on Oral Medicine VI: a systematic review of the treatment of mucocutaneous pemphigus vulgaris"],"prefix":"10.1016","volume":"120","author":[{"given":"R.","family":"McMillan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Shephard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Carrozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Setterfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Grando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mignogna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kuten-Shorrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Musbah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"McGowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.R.","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Hodgson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Sirois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oooo.2015.01.022_bib1","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1582-4934.2007.00033.x","article-title":"Immunopathology and molecular diagnosis\u00a0of autoimmune bullous diseases","volume":"11","author":"Mihai","year":"2007","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.oooo.2015.01.022_bib2","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1001\/archderm.136.12.1569","article-title":"Diagnostic patterns and delays in pemphigus vulgaris: experience with 99 patients","volume":"136","author":"Sirois","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib3","first-page":"844","article-title":"Autoimmune bullous skin diseases. Part 1: clinical manifestations","volume":"9","author":"Kneisel","year":"2011","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.oooo.2015.01.022_bib4","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1365-4632.2011.04868.x","article-title":"Paraneoplastic autoimmune multiorgan syndrome: 20 years after","volume":"50","author":"Czernik","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.det.2011.03.004","article-title":"Diagnosis and clinical features of pemphigus vulgaris","volume":"29","author":"Venugopal","year":"2011","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.oooo.2015.01.022_bib6","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1126\/science.3368786","article-title":"A\u00a0molecular basis for MHC class II\u2013associated autoimmunity","volume":"240","author":"Todd","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.oooo.2015.01.022_bib7","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/jid.2012.46","article-title":"Population-specific association between a polymorphic variant in ST18, encoding a pro-apoptotic molecule, and pemphigus vulgaris","volume":"132","author":"Sarig","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.bjoms.2007.07.205","article-title":"Oral mucosal disease: pemphigus","volume":"46","author":"Scully","year":"2008","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2015.01.022_bib9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1067\/mjd.2003.39","article-title":"History and clinical significance of mechanical symptoms in blistering dermatoses: a reappraisal","volume":"48","author":"Grando","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib10","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0190-9622(00)90213-5","article-title":"Patterns of remission in pemphigus vulgaris","volume":"42","author":"Herbst","year":"2000","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib11","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/archderm.1976.01630310024005","article-title":"Pemphigus: a 20-year review of 107 patients treated with corticosteroids","volume":"112","author":"Rosenberg","year":"1976","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0190-9622(82)70111-2","article-title":"Death in pemphigus","volume":"7","author":"Ahmed","year":"1982","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib13","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1365-2133.2008.08857.x","article-title":"Blistering skin disorders: an evidence-based update. Conference report","volume":"160","author":"Alexandroff","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib14","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMra061111","article-title":"Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome","volume":"355","author":"Stanley","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.oooo.2015.01.022_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0190-9622(99)70183-0","article-title":"The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile","volume":"40","author":"Amagai","year":"1999","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/08916934.2011.606444","article-title":"Pemphigus autoimmunity: hypotheses and realities","volume":"45","author":"Grando","year":"2012","journal-title":"Autoimmunity"},{"key":"10.1016\/j.oooo.2015.01.022_bib17","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000051540","article-title":"Autoimmunity to keratinocyte acetylcholine receptors in pemphigus","volume":"201","author":"Grando","year":"2000","journal-title":"Dermatology"},{"key":"10.1016\/j.oooo.2015.01.022_bib18","doi-asserted-by":"crossref","first-page":"e57587","DOI":"10.1371\/journal.pone.0057587","article-title":"Pemphigus vulgaris autoantibody profiling by proteomic technique","volume":"8","author":"Kalantari-Dehaghi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.oooo.2015.01.022_bib19","doi-asserted-by":"crossref","first-page":"16916","DOI":"10.1074\/jbc.M113.472100","article-title":"Mechanisms of mitochondrial damage in keratinocytes by pemphigus vulgaris antibodies","volume":"288","author":"Kalantari-Dehaghi","year":"2013","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.oooo.2015.01.022_bib20","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/j.1600-0625.2009.00934.x","article-title":"Apoptolysis: a novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis","volume":"18","author":"Grando","year":"2009","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cden.2004.08.002","article-title":"Pemphigus","volume":"49","author":"Ettlin","year":"2005","journal-title":"Dent Clin North Am"},{"key":"10.1016\/j.oooo.2015.01.022_bib22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2174\/157016309789869065","article-title":"Current treatment of autoimmune blistering diseases","volume":"6","author":"Kasperkiewicz","year":"2009","journal-title":"Curr Drug Discov Tech"},{"key":"10.1016\/j.oooo.2015.01.022_bib23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.clindermatol.2013.01.005","article-title":"Pemphigus: associations and management guidelines: Facts and controversies","volume":"31","author":"Ruocco","year":"2013","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.clindermatol.2011.03.014","article-title":"Current therapy of the pemphigus group","volume":"30","author":"Kasperkiewicz","year":"2012","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archderm.1996.03890260105016","article-title":"The adjuvant therapy of pemphigus. An update","volume":"132","author":"Bystryn","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib26","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0190-9622(03)02738-5","article-title":"Differences and similarities among expert opinions on the diagnosis and treatment of pemphigus vulgaris","volume":"49","author":"Mimouni","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib27","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.clindermatol.2011.03.013","article-title":"Immunosuppressive therapy for autoimmune bullous diseases","volume":"30","author":"Meurer","year":"2012","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib28","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/archderm.139.8.1051","article-title":"Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases","volume":"139","author":"Ahmed","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib29","first-page":"391","article-title":"Drug therapy of pemphigus vulgaris","volume":"142","author":"Ahmed","year":"2007","journal-title":"Giornale Italiano di Dermatologia e Venereologia"},{"key":"10.1016\/j.oooo.2015.01.022_bib30","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jaad.2010.04.039","article-title":"A\u00a0systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus","volume":"64","author":"Martin","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib31","first-page":"CD006263","article-title":"Interventions for pemphigus vulgaris and pemphigus foliaceus","volume":"1","author":"Martin","year":"2009","journal-title":"Cochrane database Syst Rev (Online)"},{"key":"10.1016\/j.oooo.2015.01.022_bib32","first-page":"A36","article-title":"A\u00a0systematic review of interventions for pemphigus vulgaris and pemphigus foliaceus","volume":"51","author":"Martin","year":"2010","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib33","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.oooo.2015.01.022_bib34","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"147","author":"von Elm","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.oooo.2015.01.022_bib35","series-title":"SIGN 50\u2014A Guideline Developer\u2019s Handbook","author":"Scottish Intercollegiate Guidelines Network","year":"2008"},{"key":"10.1016\/j.oooo.2015.01.022_bib36","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2133.2009.09208.x","article-title":"The use of sulfasalazine and pentoxifylline (low-cost antitumour necrosis factor drugs) as adjuvant therapy for the treatment of pemphigus vulgaris: a comparative study","volume":"161","author":"el-Darouti","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib37","first-page":"1","article-title":"Pulse versus oral methylprednisolone therapy in pemphigus vulgaris","volume":"10","author":"Shahidi-Dadras","year":"2007","journal-title":"Arch Iranian Med"},{"key":"10.1016\/j.oooo.2015.01.022_bib38","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1365-2133.2009.09034.x","article-title":"An \u2018n-of-1\u2019 placebo-controlled crossover trial of intravenous immunoglobulin as adjuvant therapy in refractory pemphigus vulgaris","volume":"160","author":"Arnold","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib39","first-page":"42","article-title":"Randomized trial of tacrolimus 0.1% ointment versus triamcinolone acetonide 0.1% paste in the treatment of oral pemphigus vulgaris","volume":"15","author":"Nazemi-Tabrizi","year":"2012","journal-title":"Iranian J Dermatol"},{"issue":"1","key":"10.1016\/j.oooo.2015.01.022_bib40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.144.1.25","article-title":"Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris","volume":"144","author":"Werth","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib41","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archderm.142.11.1447","article-title":"A\u00a0comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus","volume":"142","author":"Beissert","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib42","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/archderm.142.5.570","article-title":"Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial","volume":"142","author":"Mentink","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib43","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaad.2008.09.052","article-title":"A\u00a0randomized double-blind trial of intravenous immunoglobulin for pemphigus","volume":"60","author":"Amagai","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib44","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/jid.2010.91","article-title":"Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial","volume":"130","author":"Beissert","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib45","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaad.2007.05.024","article-title":"Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris","volume":"57","author":"Chams-Davatchi","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib46","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1468-3083.2011.04170.x","article-title":"Evaluation of mycophenolate mofetil as a steroid-sparing agent in pemphigus: a randomized, prospective study","volume":"26","author":"Ioannides","year":"2012","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.oooo.2015.01.022_bib47","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/archdermatol.2010.409","article-title":"A\u00a0pilot study of etanercept treatment for pemphigus vulgaris","volume":"147","author":"Fiorentino","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib48","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1610-0378.2005.04747.x","article-title":"Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study","volume":"3","author":"Rose","year":"2005","journal-title":"J\u00a0der Deutschen Dermatologischen Gesellschaft"},{"key":"10.1016\/j.oooo.2015.01.022_bib49","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/0378-6323.104672","article-title":"Assessment of the therapeutic benefit of dexamethasone cyclophosphamide pulse versus only oral cyclophosphamide in phase II of the dexamethasone cyclophosphamide pulse therapy: A preliminary prospective randomized controlled study","volume":"79","author":"Parmar","year":"2013","journal-title":"Ind J f Dermatol Venereol Leprol"},{"key":"10.1016\/j.oooo.2015.01.022_bib50","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaad.2008.01.012","article-title":"Consensus statement on definitions of disease, endpoints, and therapeutic response for pemphigus","volume":"58","author":"Murrell","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib51","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1056\/NEJMoa062930","article-title":"Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin","volume":"355","author":"Ahmed","year":"2006","journal-title":"New Eng J Med"},{"key":"10.1016\/j.oooo.2015.01.022_bib52","article-title":"Efficacy and safety of rituximab treatment in Indian pemphigus patients","volume":"1","author":"Kanwar","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib53","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1525-1470.2006.00195.x","article-title":"Neonatal pemphigus vulgaris in an infant born to a mother with pemphigus vulgaris in remission","volume":"23","author":"Fenniche","year":"2006","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib54","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1468-3083.2007.02550.x","article-title":"Pemphigus vulgaris associated with cocaine snorting","volume":"22","author":"Laguna","year":"2008","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.oooo.2015.01.022_bib55","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1468-3083.2006.01587.x","article-title":"Efficacy of topical PGE2 in recalcitrant oral lesions of pemphigus vulgaris: a clinical trial","volume":"20","author":"Kumaran","year":"2006","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.oooo.2015.01.022_bib56","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/jid.2011.120","article-title":"Generating consensus research goals and treatment strategies for pemphigus and pemphigoid: the 2010 JC Bystryn Pemphigus and Pemphigoid Meeting","volume":"131","author":"Schultz","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib57","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1365-4362.1994.tb01003.x","article-title":"Treatment of oral pemphigus vulgaris","volume":"33","author":"Chrysomallis","year":"1994","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib58","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/archderm.1988.01670110019004","article-title":"Controlled study of plasma exchange in pemphigus","volume":"124","author":"Guillaume","year":"1988","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib59","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1001\/archderm.136.7.868","article-title":"Ineffectiveness of cyclosporine as an adjuvant to corticosteroids in the treatment of pemphigus","volume":"136","author":"Ioannides","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib60","first-page":"38","article-title":"The clinical and laboratory research for Chinese traditional medicine in the treatment of pemphigus (Chinese)","volume":"32","author":"Luo","year":"2003","journal-title":"J\u00a0Clin Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib61","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-4362.1990.tb04765.x","article-title":"Pemphigus therapy with oral prednisolone regimens. A 5-year study","volume":"29","author":"Ratnam","year":"1990","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.oooo.2015.01.022_bib62","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/bjd.13350","article-title":"A multicentre randomized trial of the treatment of patients with pemphigus vulgaris with infliximab and prednisone compared with prednisone alone","volume":"172","author":"Hall","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib63","unstructured":"Howick J, Chalmers I, Glassziou P, et\u00a0al. The 2011 Oxford CEBM Evidence Levels of Evidence. Oxford Center for Evidence-Based Medicine. Available at: http:\/\/www.cebm.net\/index.aspx?o\u00a0= 5653; 2011. Accessed July 9, 2013."},{"key":"10.1016\/j.oooo.2015.01.022_bib64","doi-asserted-by":"crossref","first-page":"117","DOI":"10.7326\/0003-4819-147-2-200707170-00170","article-title":"Current processes of the U.S. Preventive Services Task Force: refining evidence-based recommendation development","volume":"147","author":"Guirguis-Blake","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.oooo.2015.01.022_bib65","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1398-9995.2009.01973.x","article-title":"Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions","volume":"64","author":"Brozek","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.oooo.2015.01.022_bib66","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.jclinepi.2010.07.001","article-title":"AGREE II: advancing guideline development, reporting and evaluation in health care","volume":"63","author":"Brouwers","year":"2010","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.oooo.2015.01.022_bib67","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1365-2133.2011.10575.x","article-title":"British Association of Dermatologists\u2019 guidelines for the safe and effective prescribing of azathioprine 2011","volume":"165","author":"Meggitt","year":"2011","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.oooo.2015.01.022_bib68","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/jdv.12772","article-title":"Pemphigus. S2 Guideline for diagnosis and treatment - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)","volume":"29","author":"Hertl","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.oooo.2015.01.022_bib69","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.annder.2011.01.017","article-title":"Pemphigus. Guidelines for the diagnosis and treatment [translation]. Centres de reference des maladies bulleuses auto-immunes. Societe Francaise de Dermatologie","volume":"138","author":"Joly","year":"2011","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.oooo.2015.01.022_bib70","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1365-2133.2003.05665.x","article-title":"British Association of D. Guidelines for the management of pemphigus vulgaris","volume":"149","author":"Harman","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.oooo.2015.01.022_bib71","first-page":"1695","article-title":"Comparison study of three pemphigus disease activity measurements: PDAI, ABSIS, and PVDAI","volume":"133","author":"Rahbar","year":"2013","journal-title":"J\u00a0Invest Dermatol"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440315005672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440315005672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T18:14:19Z","timestamp":1717784059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212440315005672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S2212440315005672"],"URL":"https:\/\/doi.org\/10.1016\/j.oooo.2015.01.022","relation":{},"ISSN":["2212-4403"],"issn-type":[{"value":"2212-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"World Workshop on Oral Medicine VI: a systematic review of the treatment of mucocutaneous pemphigus vulgaris","name":"articletitle","label":"Article Title"},{"value":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oooo.2015.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.oooo.2014.12.026","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.oooo.2015.03.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.oooo.2015.02.485","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.oooo.2015.01.024","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.oooo.2015.01.023","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.oooo.2014.10.027","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.oooo.2015.02.484","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}